Company Overview and News

23
Yancoal to dual list onto Hong Kong exchange

2018-07-02 theage.com.au
Coal miner Yancoal will list on the Hong Kong exchange before the end of 2018 to open its books beyond five shareholders and see movement in its share price.
YZC RTPPF K3GD RIO NOBGF RIO 1171 YZCHF N21 RIO NOBGY RTNTF

23
Yancoal to dual list onto Hong Kong exchange

2018-07-02 smh.com.au
Coal miner Yancoal will list on the Hong Kong exchange before the end of 2018 to open its books beyond five shareholders and see movement in its share price.
YZC RTPPF K3GD RIO NOBGF RIO 1171 YZCHF N21 RIO NOBGY RTNTF

135
The Zacks Analyst Blog Highlights: Autohome, Kingdee International Software Group, 58.com and Yanzhou Coal Mining

2018-04-17 zacks
Chicago, IL – April 17, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Autohome Inc. (ATHM - Free Report) , Kingdee International Software Group Company Limited (KGDEY - Free Report) , 58.com Inc. (WUBA - Free Report) and Yanzhou Coal Mining Company Ltd.
SGC K3GD STLD 1171 YZCHF WUBA ATB BAX MCHP APO 0268 YZC ATHM AMCX AMAT FSLR NEE

14
4 Stocks to Buy as Chinese Economy Remains Resilient

2018-04-16 zacks - 1
The world’s second-largest economy China has been growing by leaps and bounds for the past one year. Further, the Asian Development Bank stated in a report on Apr 11 that China would keep growing more than 6% in 2018 as well as 2019. The recent shift of focus from manufacturing to services has been pivotal in China’s economic growth story.
YZC 0268 K3GD 1171 YZCHF ATHM WUBA ATB UNF

15
The Zacks Analyst Blog Highlights: Autohome, Kingdee International Software Group, China Petroleum & Chemical, Yanzhou Coal Mining and PetroChina

2018-04-06 zacks
Chicago, IL – April 6, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Autohome Inc. (ATHM - Free Report) , Kingdee International Software Group Company Ltd. (KGDEY - Free Report) , China Petroleum & Chemical Corp.
LINDW K3GD STLD 1171 YZCHF SNP LHCG LCII CLAC ZBRA LSTR YZC 0268 CVGW SNP ATHM PATK CLACW CLACU SAIC FG LIND

14
China Manufacturing & Services PMI Improve: 5 Great Choices

2018-04-05 zacks
Even as China and the United States gear up for a trade war, China’s economy has been gaining traction. While factory activity touched its highest level since last December, services activity rebounded in March after hitting a four-month low in the prior month. Increase in steel production and removal of winter pollution restrictions contributed to these gains.
YZC 0268 SNP K3GD 1171 YZCHF ATHM SNP VIRT

50
Rio Exits Coal Business With $4 Billion of Deals in a Week - Bloomberg

2018-03-28 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
K3GD RIO BLT RIO 1171 YZCHF BHPBF AAL YZC RTPPF BHP UBS AAUKF RIO RTNTF BBL BHP BHPLF NGLOY ULSGF

 
Shenhua Profit Rises to 5-Year High as China Curbs Boost Coal - Bloomberg

2018-03-25 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
1898 YACAF YZC K3GD 1171 YZCHF YAL 1088

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to YZC / Yanzhou Coal Mining Company Ltd. on message board site Silicon Investor.

YZC - Yanzhou Coal Mining - IPO priced at $15.75 YZC - Yanzhou Coal Mining - IPO priced at $15.75 YZC - Yanzhou Coal Mining - IPO priced at $15.75
CUSIP: 984846105